ir.adamaspharma.com
Investors - Adamas Pharmaceuticals, Inc.The Investor Relations website contains information about Adamas Pharmaceuticals, Inc. business for stockholders, potential investors, and financial analysts.
http://ir.adamaspharma.com/
The Investor Relations website contains information about Adamas Pharmaceuticals, Inc. business for stockholders, potential investors, and financial analysts.
http://ir.adamaspharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
1.5 seconds
PAGES IN
THIS WEBSITE
17
SSL
EXTERNAL LINKS
85
SITE IP
206.200.251.19
LOAD TIME
1.528 sec
SCORE
6.2
Investors - Adamas Pharmaceuticals, Inc. | ir.adamaspharma.com Reviews
https://ir.adamaspharma.com
The Investor Relations website contains information about Adamas Pharmaceuticals, Inc. business for stockholders, potential investors, and financial analysts.
ir.adamaspharma.com
Investors - Adamas Pharmaceuticals, Inc.
http://ir.adamaspharma.com/analysts.cfm
Scientific & Clinical Advisors. ADS-5102 in MS Gait. ADS-5102 in MS Gait. Patient Frequently Asked Questions (FAQs). Events & Presentations. Presentations & Publications. Please email ir@adamaspharma.com. For assistance with Investor Relations questions. Namzaric™ is a trademark of Merz Pharma GmbH and Co. KGaA. Namenda XR is a registered trademark of Merz Pharma GmbH and Co. KGaA. 4:00 PM ET on Aug 18, 2016. Delayed at least 20 minutes. Aug 4, 2016. Adamas Reports Second Quarter 2016 Financial Results.
Stock Information - Adamas Pharmaceuticals, Inc.
http://ir.adamaspharma.com/stockquote.cfm
Scientific & Clinical Advisors. ADS-5102 in MS Gait. ADS-5102 in MS Gait. Patient Frequently Asked Questions (FAQs). Events & Presentations. Presentations & Publications. Please email ir@adamaspharma.com. For assistance with Investor Relations questions. 4:00 PM ET on Aug 18, 2016. Sign up for email alerts. 2016 Adamas Pharmaceuticals, Inc.
Investors - Adamas Pharmaceuticals, Inc.
http://ir.adamaspharma.com/index.cfm
Scientific & Clinical Advisors. ADS-5102 in MS Gait. ADS-5102 in MS Gait. Patient Frequently Asked Questions (FAQs). Events & Presentations. Presentations & Publications. Please email ir@adamaspharma.com. For assistance with Investor Relations questions. Namzaric™ is a trademark of Merz Pharma GmbH and Co. KGaA. Namenda XR is a registered trademark of Merz Pharma GmbH and Co. KGaA. 4:00 PM ET on Aug 18, 2016. Delayed at least 20 minutes. Aug 4, 2016. Adamas Reports Second Quarter 2016 Financial Results.
Events & Presentations - Adamas Pharmaceuticals, Inc.
http://ir.adamaspharma.com/events.cfm
Scientific & Clinical Advisors. ADS-5102 in MS Gait. ADS-5102 in MS Gait. Patient Frequently Asked Questions (FAQs). Events & Presentations. Presentations & Publications. Please email ir@adamaspharma.com. For assistance with Investor Relations questions. Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. Jul 12, 2016. Aug 4, 2016. Second Quarter 2016 Financial Results. 2016 Adamas Pharmaceuticals, Inc.
Press Releases - Adamas Pharmaceuticals, Inc.
http://ir.adamaspharma.com/releases.cfm
Scientific & Clinical Advisors. ADS-5102 in MS Gait. ADS-5102 in MS Gait. Patient Frequently Asked Questions (FAQs). Events & Presentations. Presentations & Publications. Please email ir@adamaspharma.com. For assistance with Investor Relations questions. Adamas Reports Second Quarter 2016 Financial Results. Aug 4, 2016. Allergan and Adamas Announce New Expanded Indication for NAMZARIC (Memantine and Donepezil Hydrochlorides) Extended Release for the Treatment of Moderate to Severe Alzheimer's Disease.
TOTAL PAGES IN THIS WEBSITE
17
Acorda Therapeutics Inc - Investors
Investors span LayoutHomePageLayout Languageen-CA". Policy on Access to. Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Policy on Access to. March 26, 2018. Acorda Files Marketing Authorization Application for INBRIJA (levodopa inhalation powder). March 14, 2018. Acorda Rallies Parkinson’s Community in First-of-Its-Kind Initiative to Foster Better Conversations About Parkinson’s Symptoms.
Investor Relations Home - Investor Relations - American Capital Senior Floating
Skip to main content. Dividend Reinvestment and Stock Purchase. Receive American Capital Senior Floating. 10-Q Q2 2015 (quarter ending June 30, 2015). 10-Q Q1 2015 (quarter ending March 31, 2015). American Capital Senior Floating, Ltd. Announces Monthly Cash Dividends of $0.097 per Share for August, September and October of 2015. American Capital Senior Floating Reports Net Investment Income of $0.32 per Share. American Capital Senior Floating, Ltd. Will Report Second Quarter 2015 Results on August 3.
Investor Relations :: Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference. Jan 10, 2017. Ended Sep 30, 2016. Actinium Pharmaceuticals, Inc. Actinium Pharmaceuticals, Inc. New York, NY 10016. 2469 E. Fort Union Blvd. Salt Lake City, UT 84121. Receive the latest news, events and updates! 2017 Actinium Pharmaceuticals, Inc.
Investor Overview - Active Power Investors Relations
150 kVA â 1200 kVA). 750 kVA â 3 MVA). Our products are built on our elegant, field proven flywheel technology that delivers an unmatched combination of power density, reliability, and total cost of ownership. This combination enables our customers to achieve their availability, reliability, and budget goals. Q2 2015 Earnings Release. Q2 2015 Active Power, Inc. Earnings Conference Call. Q2 2015 â 10-Q. 160; 0.08. Data as of 08/07/15Â 4:00 pm ET. Minimum 20 minute delay. Active Power to Present at 43rd An...
Activision Blizzard, Inc. | Investor Relations
Activision Blizzard, Inc. is the largest and most profitable western interactive entertainment publishing company. It develops and publishes some of the most successful and beloved entertainment franchises in any medium, including. Call of Duty,. Call of Duty Online,. Aug 6, 2015. Hellfire Rains on Azeroth in World of Warcraft: Legion™. Aug 5, 2015. Activision Brings Strongest Ever Line-up to Gamescom 2015. Aug 4, 2015 at 1:30 PM PT. Activision Blizzard Second Quarter Calendar 2015 Results Conference Call.
Investors - Adamas Pharmaceuticals, Inc.
Scientific and Clinical Advisors. Please email ir@adamaspharma.com. For assistance with Investor Relations questions. Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system. The company seeks to achieve this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products. 4:00 PM ET on Aug 14, 2015.
Overview | Investors | Adamis
11682 El Camino Real, Suite # 300. San Diego, CA 92130. Investor Relations and Media Contact:. Director, Investor Relations and Corporate Communications. First American Stock Transfer. 4747 N. 7th Street, Suite # 170. Phoenix, AZ 85014. Mayer Hoffman McCann P.C. Http:/ www.mhm-pc.com. Weintraub Tobin Chediak Coleman Grodin. No Duty to Update. Data provided by Nasdaq. Minimum 15 minutes delayed. Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA.
Home Page - AdCare Health Systems
15879 N. 80th Street. Scottsdale, AZ 85260. AdCare Health Systems seeks to enhance shareholder value not only through exceptional. Business performance and practices, but also through responsible and effective. Communication with its shareholders. The latest company information relevant to the. Individual and institutional investor includes stock price and history, upcoming events and. Presentations and financial documents. AdCare Health Systems is traded on the NYSE under the ticker symbol ADK. See impo...
Adecoagro
Presentation and Conference Calls. 20-F 2016 Annual Report. Mariano Bosch (CEO) live on Bloomberg TV. Listen to Webcast (Portuguese). Listen to Webcast (English). Adecoagro Presentó a SanCor una Alternativa de Inversión y Asociación. Click para más información. Adecoagro Submits Investment Proposal to Partner with SanCor. Click here for more information.
Adept Technology, Inc. - Investor Relations
Adept Technology, Inc. Aug 7, 2015. Quotes delayed at least 20 minutes. Information provided by eSignal. The Company has been featured in several publications including Fortune, Inc., Business Week, Forbes ASAP, Red Herring, Industry Week. And The New York Times. Adept Technology will be the global leader in the manufacturing, marketing and innovation of robotics, vision and motion control products for automated material handling and assembly. Click here for 2014 Proxy information. Jul 27, 2015.
Adeptus Health Inc. - IR Home
A new holding company focused on premier healthcare organizations that provide communities access to the highest quality medical care. August 14, 2015. July 29, 2015. Adeptus Health Inc. Announces Pricing of Common Stock Offering. July 27, 2015. Adeptus Health Inc. Announces Common Stock Offering. July 23, 2015. Adeptus Health Reports Second Quarter 2015 Results And Raises Full Year Guidance. There are no events scheduled at this time. Powered By Q4 Web Systems.
SOCIAL ENGAGEMENT